Abstract:The ageing population continues to suffer from its primary killer, cardiovascular disease (CVD). Despite recent advances in interventional medicinal and surgical therapies towards the end of the 20th century, the epidemic of cardiovascular disease has not been halted. Yet, rather than receding globally, the burden of CVD has risen to become a top cause of morbidity and mortality worldwide. Most CVD arises from thrombotic rupture of an atherosclerotic plaque, the pathologic thickening of coronary and carotid artery segments and subsequent distal ischemia in heart or brain. In fact, one-fifth of deaths are directly attributable to thrombotic rupture of a vulnerable plaque. Atherosclerotic lesion formation is caused by a concert of interactions between circulating leukocytes and platelets, interacting with the endothelial barrier, signalling into the arterial wall by the release of cytokines and extracellular vesicles (EVs). Both platelet- and cell-derived EVs represent a novel mechanism of cellular communication, particularly by the transport and transfer of cargo and by reprogramming of the recipient cell. These interactions result in phenotypic switching of vascular smooth muscle cells (VSMCs) causing migration and proliferation, and subsequent secretion of EVs. Loss of VSMCs attracts perivascular Mesenchymal Stem Cells (MSCs) from the adventitia, which are a source of VSMCs and contribute to repair after vascular injury. However, continuous stress stimuli eventually switch phenotype of cells into osteochondrogenic VSMCs facilitating vascular calcification. Although Virchow's triad is over 100 years old, it is a reality that is accurate today. It can be briefly summarised as changes in the composition of blood (platelet EVs), alterations in the vessel wall (VSMC phenotypic switching, MSC infiltration and EV release) and disruption of blood flow (atherothrombosis). In this paper, we review the latest relevant advances in the identification of extracellular vesicle pathways as well as VSMCs and pericyte/MSC phenotypic switching, underlying vascular calcification.

[Vascular Calcification - Pathological Mechanism and Clinical Application - . Role of vascular smooth muscle cells in vascular calcification]

Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities

Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT

[The mechanisms of medial vascular calcification].

[Bone metabolism and cardiovascular function Update. Vascular calcification as a manifestation of bone-vascular axis]

Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness

Vascular Calcification: A Passive Process That Requires Active Inhibition

Vascular Calcification—New Insights into Its Mechanism

Involvement of Vitamin K-Dependent Proteins in Vascular Calcification

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

Medial Vascular Calcification: a New Concept Challenging the Classical Paradigm of Dystrophic Calcification

Vascular Calcification in Chronic Kidney Disease is Induced by Bone Morphogenetic Protein-2 Via a Mechanism Involving the Wnt/β-Catenin Pathway

Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon?

Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles

Vascular Calcification: New Insights Into BMP Type I Receptor A

Vascular Calcification: In Vitro Models under the Magnifying Glass

Cell-Matrix Interactions and Matricrine Signaling in the Pathogenesis of Vascular Calcification

Research Progress of Mechanisms on Formation and Regression in Vascular Calcification

Wnt Signaling in Vascular Calcification

Role of Macrophages in the Progression and Regression of Vascular Calcification

A simple and rapid model of vascular calcification